Intercept Pharmaceuticals | ICPT - Spese Di Vendita E Di Amministrazione



Spese Di Vendita E Di Amministrazione Cambiamento Data
Acadia Pharmaceuticals USD 148.57M 12.22M 2026-06
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Amarin USD 18.97M 1.03M 2025-12
Amgen USD 1.72B 134M 2026-06
Arrowhead Research USD 46.63M 4.88M 2026-06
AstraZeneca USD 4.07B 1.73B 2026-09
Biogen USD 752M 42.3M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Galectin Therapeutics USD 1.48M 110K 2024-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Incyte USD 364.27M 12.54M 2026-09
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
Moderna USD 216M 43M 2026-06
Neurocrine Biosciences USD 366.3M 16.8M 2026-09
Novartis USD 3.08B 163M 2026-09
PTC Therapeutics USD 80.63M 6.74M 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09